Sep 14,2021 01:00 PM
Lupin dragged 0.4% at Rs980.15 per piece while Torrent Pharma was also 0.13% lower.
Volumes soar at Divis Laboratories Ltd counter Aug 11,2021
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||772.80||87.08||183,441.16||419.30||0.98||3,312.54||104.36|
|Divis Laboratories Ltd||5,166.90||68.25||137,482.20||551.97||0.39||1,950.16||349.25|
|Dr Reddys Laboratories Ltd||4,846.00||48.96||80,774.79||413.40||0.52||3,410.10||1,032.60|
|Gland Pharma Ltd||3,873.00||61.32||63,408.69||350.68||0.00||1,153.90||359.44|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Divis Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies. Divis is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas. The company has four ... More
Reports by divis-laboratories-ltd-share-price
Sep 22, 2021 02:17 PM
The company’s standalone revenue stood at Rs1,342.92cr, up 29.39% yoy and 4.51% qoq.
30 Aug 2021
19 Jul 2021
AGM 30/08/2021We hereby inform that the 31st Annual General Meeting of the Company is scheduled to b... More
29 May 2021
17 Aug 2021
As per enclosed... More
07 Aug 2021
30 Jul 2021
DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More